Stay updated on ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Sign up to get notified when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.

Latest updates to the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page
- Check3 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 at the top of the page; no study content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check10 days agoChange DetectedShow glossary toggle was added and QC/FEAR Act-related metadata labels were updated: 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' were added, while 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedAdded a new publication citation for Hoffmann et al. in Muscle Nerve (2026) and updated the page revision to v3.3.4.SummaryDifference0.1%

- Check46 days agoChange DetectedThe study locations section has been reorganized and expanded to group sites under 'Locations' by U.S. states, Canadian provinces, and selected international regions (Chiba, Hokkaido, Miyagi, Osaka, Tokyo), and the revision version updated from v3.3.2 to v3.3.3.SummaryDifference2%

- Check74 days agoChange DetectedThe Publications section now states that PubMed-sourced publications are auto-filled and may not all pertain to the study, and the revision label was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check81 days agoChange DetectedThe notice about government funding status (outlining NIH operations and potential delays) was removed from the page, reducing clutter without impacting the study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARGX-113 in Myasthenia Gravis: Efficacy Study Clinical Trial page.